Back to mobile site

Mesoblast (MESO) Upcoming Data Readouts Should Boost Valuation - Maxim

June 7, 2018 1:53 PM EDT Send to a Friend
Maxim Group maintains Buy on Mesoblast Limited (NASDAQ: MESO) price target of $14.00.Analyst Jason McCarthy comments "Mesoblast has multiple ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login